IGP2012The 1985 International Guiding Principles for Biomedical Research Involving Animals have been revised by an ad hoc committee appointed by the Council for International Organizations of Medical Sciences (CIOMS) and the International Council for Laboratory Animal Science (ICLAS).

The revised International Guiding Principles for Biomedical Research Involving Animals reflect current best practices and standards of care in laboratory animal medicine and science and provide a touchstone or framework of responsibility and oversight to ensure the appropriate use of animals.  They also may serve as a benchmark for advancing international collaboration in biomedical sciences.

It is hoped that international organizations and governmental agencies will adopt these revised International Guiding Principles for Biomedical Research Involving Animals and that they will encourage use by the scientific community worldwide.

pdfclick here to download document

New Books



Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX  

The Council for International Organizations of Medical Sciences (CIOMS) announces the publication...

Read more...

 

New Meetings

5th Vaccine Safety Working Group, Rabat, Morocco, 24-25 September 2014

8th Working Group X on Meta-analysis, Basel, Switzerland, 30 September – 1 October 2014

MedDRA 6th IWG Meeting, ICH, Geneva, Switzerland, 14-16 October 2014

7th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 12-14 November 2014

81st CIOMS Executive Committee Meeting, Geneva, Switzerland, 18 November 2014

Recent Meetings

6th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 21-23 May 2014

4th Vaccine Safety Working Group, UMC, Uppsala, Sweden, 20-21 May 2014

5th Working Group on MedDRA, ICH, Geneva, Switzerland, 9-10 April 2014

5th Working Group on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 26-28 February 2014

7th Working Group X on Meta-analysis, Durham, North Carolina, USA, 25-26 February 2014

3rd Vaccine Safety Working Group, CDC, Atlanta, GA, USA, 5-6 February 2014

CIOMS 80th Executive Committee Meeting, XXI General Assembly & Workshop, 20 November 2013, WHO Headquarters, Geneva, Switzerland

CIOMS 4th Working Group on Revision of CIOMS International Ethical Guidelines, 17-19 November 2013, WHO Headquarters, Geneva, Switzerland

CIOMS Working Group on Vaccine Safety, 17-18 September  2013, WHO Headquarters, Geneva, Switzerland

CIOMS WG X on Considerations for applying good meta-analysis practices to clinical safety data within the biopharmaceutical regulatory process, 12-13 September 2013, Singapore

CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 26-28 June 2013, UMC, Utrecht, The Netherlands

CIOMS WG on Vaccine Safety, 29-30 May 2013 , EMA, London, UK

CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 11-12 February 2013, Geneva, Switzerland

CIOMS Working Group X, 14-15 March 2013, MEB, Utrecht, The Netherlands

CIOMS Working Group IX, 18-19 March 2013, NDA, Stockholm, Sweden

MedDRA 3rd IWG Meeting, 9-10 April 2013, IFPMA/CIOMS, Geneva, Switzerland

WHO on Twitter
WHO WHO welcomes Canada’s @PHAC_GC donation of lead candidate #Ebola vaccines. First shipment arrived in Geneva http://t.co/TdYRoINH0u
9h
WHO Dr Raviglione thanks you very much for all your Qs on #tuberculosis, MDR-TB during this #TBChat. To sum up, the facts http://t.co/rmqnCKsT11
11h
WHO .@arsal0404 Latest guidelines on the management of MDR-#TB just published: http://t.co/uwtR9Uy11M #TBChat
11h
WHO .@copylefft Low quality drugs may induce development of #Tuberculosis drug resistance. Quantification of this is difficult #TBChat
11h
WHO @ladykayaker 6 months is standard.
11h

Visitors

722592

Member Login